Two Whistleblowers Cut Out Of $193M Endo Settlement
A Pennsylvania federal court ruled Monday that only one of three whistleblowers can take a portion of Endo Pharmaceuticals Inc.'s $193 million settlement with the U.S. Department of Justice over the...To view the full article, register now.
Already a subscriber? Click here to view full article